LC-MS based serum metabonomic analysis for renal cell carcinoma diagnosis, staging, and biomarker discovery

2011 ◽  
Vol 10 (3) ◽  
pp. 1396-1405 ◽  
Author(s):  
Lin Lin ◽  
Zhenzhen Huang ◽  
Yao Gao ◽  
Xiaomei Yan ◽  
Jinchun Xing ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Biomarker Discovery

Differential Protein Expressions in Renal Cell Carcinoma: New Biomarker Discovery by Mass Spectrometry

2009 ◽  
Vol 8 (8) ◽  
pp. 3797-3807 ◽  
Author(s):  
K. W. Michael Siu ◽  
Leroi V. DeSouza ◽  
Andreas Scorilas ◽  
Alexander D. Romaschin ◽  
R. John Honey ◽  
...  
Keyword(s):  
Mass Spectrometry ◽  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Biomarker Discovery ◽  
Differential Protein ◽  
Protein Expressions

scholarly journals Potential Approaches and Recent Advances in Biomarker Discovery in Clear-Cell Renal Cell Carcinoma

2015 ◽  
Vol 6 (11) ◽  
pp. 1105-1113 ◽  
Author(s):  
Weronika Majer ◽  
Katarzyna Kluzek ◽  
Hans Bluyssen ◽  
Joanna Wesoły
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Biomarker Discovery ◽  
Clear Cell ◽  
Cell Renal Cell Carcinoma ◽  
Recent Advances

A pilot investigation of a urinary metabolic biomarker discovery in renal cell carcinoma

2019 ◽  
Vol 52 (3) ◽  
pp. 437-446 ◽  
Author(s):  
Mingxin Zhang ◽  
Xiaoyan Liu ◽  
Xiang Liu ◽  
Hanzhong Li ◽  
Wei Sun ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Biomarker Discovery ◽  
Pilot Investigation

scholarly journals Advancing the Science and Management of Renal Cell Carcinoma: Bridging the Divide between Academic and Community Practices

2020 ◽  
Vol 9 (5) ◽  
pp. 1508 ◽  
Author(s):  
Nicholas J. Salgia ◽  
Errol J. Philip ◽  
Mohammadbagher Ziari ◽  
Kelly Yap ◽  
Sumanta Kumar Pal
Keyword(s):  
Renal Cell Carcinoma ◽  
Clinical Trials ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Biomarker Discovery ◽  
Tertiary Care ◽  
Patient Recruitment ◽  
Tertiary Care Centers ◽  
Made In

The treatment of metastatic renal cell carcinoma (mRCC) has rapidly evolved; however, the progress made in the field is heavily contingent upon timely and efficient accrual to clinical trials. While a substantial proportion of accrual occurs at tertiary care centers, community sites are playing an increasing role in patient recruitment. In this article, we discuss strategies to optimize collaborations between academic and community sites to facilitate clinical research. Further, as the role of biomarker discovery has become increasingly important in tailoring therapy, we will discuss opportunities to bridge diverse accrual sites for the purpose of translational research.

scholarly journals Combined Blood/Tissue Analysis for Cancer Biomarker Discovery: Application to Renal Cell Carcinoma

2010 ◽  
Vol 82 (5) ◽  
pp. 1584-1588 ◽  
Author(s):  
Donald J. Johann ◽  
Bih-Rong Wei ◽  
DaRue A. Prieto ◽  
King C. Chan ◽  
Xiaying Ye ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Biomarker Discovery ◽  
Cancer Biomarker ◽  
Tissue Analysis

Metabolomic insights into pathophysiological mechanisms and biomarker discovery in clear cell renal cell carcinoma

2019 ◽  
Vol 19 (5) ◽  
pp. 397-407 ◽  
Author(s):  
Giuseppe Lucarelli ◽  
Davide Loizzo ◽  
Rossana Franzin ◽  
Stefano Battaglia ◽  
Matteo Ferro ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Biomarker Discovery ◽  
Clear Cell ◽  
Cell Renal Cell Carcinoma ◽  
Pathophysiological Mechanisms
Sign in / Sign up

Export Citation Format

Share Document